1. Analysis of transmitted drug resistance in Spain in the years 2007–2010 documents a decline in mutations to the non-nucleoside drug class 
S. Monge, V. Guillot, M. Alvarez, A. Peña, P. Viciana, S. García-Bujalance, M.J. Pérez Elias, J.A. Iribarren, F. Gutiérrez, M. Itziar Casado 
Clinical Microbiology and Infection 
Volume 18, Issue 11, Pages E485-E490 (November 2012)
DOI: /
Copyright © 2012 European Society of Clinical Infectious Diseases Terms and Conditions

2. FIG. 1
Prevalence of TDR by antiretroviral family and non-B subtypes between 2007 and NRTI, nucleoside reverse transcriptase inhibitors; NNRTI, non-nucleoside reverse transcriptase inhibitors; PI, protease inhibitors. CRFs, circulating recombinant forms. A significant decreasing trend was found for resistance to NNRTIs (p for trend = 0.044).
Clinical Microbiology and Infection  , E485-E490DOI: ( / )
Copyright © 2012 European Society of Clinical Infectious Diseases Terms and Conditions